SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549

                                    FORM 10-Q


                 QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934




For Quarter Ended               January 30, 1999      
Commission File Number               0-3319   


                          DEL GLOBAL TECHNOLOGIES CORP.
                          -----------------------------
             (Exact name of registrant as specified in its charter)


             New York                                     13-1784308        
             --------                                     ----------        
  (State or other jurisdiction of                      (I.R.S. Employer
   incorporation or organization)                      Identification No.)

                      One Commerce Park, Valhalla, NY 10595
                      -------------------------------------
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (914) 686-3600
                                 --------------
               (Registrant's telephone number including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

Yes   X                No       

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the close of the business on March 11, 1999.



                            Common Stock - 7,709,985




<PAGE>





                                     PART I


Item 1.  Financial Statements

              Consolidated Balance Sheets - January 30, 1999 and August 1, 1998

              Consolidated  Statements  of Income  for the Three  Months and Six
              Months ended January 30, 1999 and January 31, 1998

              Consolidated  Statements  of Cash Flows for the Six  Months  ended
              January 30, 1999 and January 31, 1998

              Notes to Consolidated Financial Statements


                                       -1-

<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                                   (Unaudited)

                                     ASSETS
                                                       January 30,   August  1,
                                                          1999          1998  
                                                       -----------   ----------
CURRENT ASSETS
        Cash and cash equivalents                     $   883,299   $ 3,401,697
        Investments available-for-sale                  1,084,088       913,125
        Trade receivables - net                        15,353,620    14,341,744
        Cost and estimated earnings
             in excess of billings on
             uncompleted contracts                      4,761,238     3,306,673
        Inventory                                      33,658,710    29,195,262
        Prepaid expenses and other
             current assets                             2,183,709     1,358,847
                                                      -----------   -----------
             Total current assets                      57,924,664    52,517,348
                                                      -----------   -----------

FIXED ASSETS - Net                                     13,398,554    12,739,509
INTANGIBLES - Net                                         855,669       941,443
GOODWILL - Net                                          5,539,085     4,809,255
DEFERRED CHARGES                                          325,687       387,044
OTHER ASSETS                                              971,291       962,028
                                                      -----------   -----------
        TOTAL                                         $79,014,950   $72,356,627
                                                      ===========   ===========

                      LIABILITIES AND SHAREHOLDERS' EQUITY


CURRENT LIABILITIES
         Current portion of long-term debt            $   552,478   $   120,410
         Accounts payable - trade                       6,665,750     5,403,403
         Accrued liabilities                            4,109,372     3,938,623
         Deferred compensation liability                1,125,052       913,046
         Income taxes                                   1,021,581       394,540
                                                      -----------   -----------
              Total current liabilities                13,474,233    10,770,022
                                                      -----------   -----------

LONG-TERM LIABILITIES
         LONG-TERM DEBT (less current
              portion included above)                   1,191,906       240,273
         OTHER                                            429,370       484,366
         DEFERRED INCOME TAXES                          1,590,536     1,406,162
                                                      -----------   -----------
              Total liabilities                        16,686,045    12,900,823
                                                      -----------   -----------

SHAREHOLDERS' EQUITY
         Common stock, $.10 par value;
              Authorized 20,000,000
              shares; Issued and
              outstanding 8,119,272
              shares at January 30, 1999
              and 7,988,993 shares at
              August 1, 1998                              811,926       798,898
         Additional paid-in capital                    49,713,213    49,124,456
         Retained earnings                             15,394,436    12,360,906
                                                      -----------   -----------
                                                       65,919,575    62,284,260
         Less common stock in treasury -
              396,887 shares at January 30, 1999
              and 299,746 at August 1, 1998             3,590,670     2,828,456
                                                      -----------   -----------
              Total shareholders' equity               62,328,905    59,455,804
                                                      -----------   -----------
         TOTAL                                        $79,014,950   $72,356,627
                                                      ===========   ===========

   See notes to consolidated financial statements


                                       -2-

<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                        CONSOLIDATED STATEMENTS OF INCOME

                                   (Unaudited)

<TABLE>
<CAPTION>
                                      Three Months Ended             Six Months Ended       
                                 ---------------------------    --------------------------  
                                  January 31,    January 30,     January 30,    January 31,
                                     1999           1998            1999           1998
                                 ------------   ------------    ------------   ------------
<S>                              <C>            <C>             <C>            <C>         
NET SALES                        $ 15,921,952   $ 14,403,182    $ 30,731,618   $ 27,883,251
                                 ------------   ------------    ------------   ------------
COSTS AND EXPENSES:
     Cost of sales                  9,308,253      8,503,015      17,987,421     16,550,560
     Research and development       1,522,929      1,464,357       2,954,243      2,700,246
     Selling, general and
         administrative             2,749,659      2,476,438       5,370,821      4,878,837
     Interest expense (income)
         - net                         15,831        (44,275)         22,712        (98,550)
                                 ------------   ------------    ------------   ------------
                                   13,596,672     12,399,535      26,335,197     24,031,093
                                 ------------   ------------    ------------   ------------
INCOME BEFORE PROVISION
     FOR INCOME TAXES               2,325,280      2,003,647       4,396,421      3,852,158
PROVISION FOR INCOME TAXES            720,836        641,167       1,362,890      1,232,691
                                 ------------   ------------    ------------   ------------
NET INCOME                       $  1,604,444   $  1,362,480    $  3,033,531   $  2,619,467
                                 ============   ============    ============   ============

NET INCOME PER COMMON
     SHARE AND COMMON SHARE
     EQUIVALENTS:
     BASIC                       $        .21   $        .18    $        .40   $        .35
                                 ============   ============    ============   ============
     DILUTED                     $        .20   $        .17    $        .37   $        .32
                                 ============   ============    ============   ============
Weighted average number of
common shares outstanding           7,648,308      7,472,140       7,648,361      7,455,775
                                 ============   ============    ============   ============
Weighted average number of
common shares outstanding and
      common share equivalents      8,205,600      8,172,285       8,174,078      8,172,142
                                 ============   ============    ============   ============
</TABLE>


See notes to consolidated financial statements

                                              

                                       -3-

<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

                                                          Six months ended 
                                                     ---------------------------
                                                     January 30,    January 31,
                                                        1999           1998
                                                     -----------    -----------
CASH FLOWS FROM OPERATING ACTIVITIES:
   Net Income                                        $ 3,033,530    $ 2,619,467
     Adjustments to reconcile net income
       to net cash (used in) provided by
       operating activities net of effects of
       purchase of Acoma Medical Imaging Inc.:
       Depreciation                                      843,725        657,821
       Amortization                                      322,676        264,646
       Deferred income tax provision                     184,374        114,759
       Tax benefit from exercise of stock
          options and warrants                           131,391        325,594
       Imputed interest                                   10,974         46,793
       Amortization of stock based compensation           11,215         79,047
       Changes in assets and liabilities:
          Increase in trade receivables               (1,011,876)    (1,171,081)
          Increase in cost and estimated earnings
             in excess of billings on uncompleted
             contracts                                (1,454,565)      (193,669)
          Increase in inventory                       (4,013,448)    (1,620,728)
          Increase in prepaid and other current
             assets                                     (869,686)      (652,476)
          Increase in other assets                        (9,983)       (17,259)
          Increase in accounts payable - trade         1,262,347        559,812
          Increase (decrease) in accrued
             liabilities                                 170,749       (242,319)
          Increase in deferred compensation
             liability                                   212,006         94,141
          Increase (decrease) in income taxes
             payable                                     627,041        (77,745)
                                                     -----------    -----------
   Net cash (used in) provided by operating
       activities                                       (549,530)       786,803
                                                     -----------    -----------

CASH FLOWS FROM INVESTING ACTIVITIES:
        Net cash paid on acquisition of
          subsidiaries                                  (509,219)          --
        Expenditures for fixed assets                 (1,502,770)    (1,218,395)
        Investment in marketable securities             (170,963)      (131,888)
        Payments to former shareholders of
          subsidiary acquired                            (60,186)       (27,829)
                                                     -----------    -----------
   Net cash used in investing activities              (2,243,138)    (1,378,112)
                                                     -----------    -----------

CASH FLOWS FROM FINANCING ACTIVITIES:
        Net proceeds from (repayment of) bank
          borrowing                                      583,701        (66,198)
        Payment for repurchase of shares                (692,474)      (918,129)
        Proceeds from exercise of stock options
          and warrants                                   328,500        841,153
        Other                                             54,543         41,453
                                                     -----------    -----------
   Net cash provided by (used in) financing
        activities                                       274,270       (101,721)
                                                     -----------    -----------

                                                                     (Continued)
See notes to consolidated financial statements


                                       -4-

<PAGE>







                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (Unaudited)


                                                         Six months ended   
                                                   ----------------------------
                                                   January 30,      January 31,
                                                      1999             1998
                                                   -----------      -----------
NET DECREASE IN CASH AND CASH EQUIVALENTS          $(2,518,398)     $  (693,030)
CASH AND CASH EQUIVALENTS, BEGINNING OF
PERIOD                                               3,401,697        6,070,608
                                                   -----------      -----------
CASH AND CASH EQUIVALENTS, END OF PERIOD           $   883,299      $ 5,377,578
                                                   ===========      ===========

SUPPLEMENTAL DISCLOSURES OF CASH FLOW
   INFORMATION:
      Interest paid                                $    75,698      $    62,587
                                                   ===========      ===========
      Income taxes paid                            $   419,469      $   865,083
                                                   ===========      ===========

SUPPLEMENTAL SCHEDULE OF INVESTING AND
   FINANCING ACTIVITIES:

   Acquisition of selected assets                  $ 1,309,219   

   Payment due under acquisition term note            (800,000)
                                                   -----------

   Net cash paid to acquire selected assets        $   509,219
                                                   ===========






See notes to consolidated financial statements


                                       -5-

<PAGE>
                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                                   (Unaudited)

NOTE  1        In the  opinion of the  Company's  management,  the  accompanying
               unaudited   consolidated   financial   statements   contain   all
               adjustments  (consisting  of only normal  recurring  adjustments)
               necessary  to  present   fairly  the  results  of  the  Company's
               financial  position as of January 30, 1999 and the results of its
               operations  and its cash flows for the six months  ended  January
               30, 1999 and January 31, 1998.

               The accounting  policies followed by the Company are set forth in
               Note 1 to the  Company's  financial  statements  as of  August 1,
               1998.

               The  consolidated   financial   statements   should  be  read  in
               conjunction  with the  notes to the  financial  statements  as of
               August 1, 1998.

               Certain  reclassifications  have been made in the prior  period's
               financial  statements  to  correspond  to  the  current  period's
               presentation.

NOTE 2         The  results  of  operations  for the  three  month and six month
               periods ended January 30, 1999 are not necessarily  indicative of
               the results to be expected for the full year.


NOTE 3         INVESTMENTS AND DEFERRED COMPENSATION

               At January 30,  1999,  the Company  had set aside  $1,125,042  of
               deferred   compensation   for  its   President  and  certain  key
               executives.  Of this amount  $123,963 was in cash and  $1,001,089
               was in  investments  available-for-sale.  Included in investments
               available-for-sale  are  $82,999  are U. S.  Treasury  bonds  and
               equity securities held by the Company for its own account and are
               recorded  at fair  market.  At August 1, 1998,  the  Company  had
               $913,046 of deferred  compensation for its President which was in
               investments   available-for   sale.  The  deferred   compensation
               liability  at January 30, 1999 and August 1, 1998 was  $1,125,042
               and $913,046,  respectively.  Gains and losses on the investments
               held to fund the  deferred  compensation,  either  recognized  or
               realized, inure to the benefit or detriment of the President's or
               key executives'  individual deferred  compensation.  Realized and
               unrealized gains and losses on investments held for the Company's
               account in the six month period  ended  January 30, 1999 were not
               material and are recorded in the financial statements.


NOTE 4         PERCENTAGE OF COMPLETION ACCOUNTING
                                                                   Six Months
                                                                     Ended
                                         January 30,    August 1,  January 30,
                                            1999          1998        1999     
                                         -----------  -----------  ----------- 
               Costs incurred on
                  uncompleted contracts  $10,460,295  $ 6,804,554  $ 3,655,741

               Estimated earnings          6,422,245    4,178,103    2,244,142
                                         -----------  -----------  -----------
                                          16,882,540   10,982,657    5,899,883

               Less billings to date      12,121,302    7,675,984    4,445,318
                                         -----------  -----------  -----------

               Costs and estimated
                  earnings in excess
                  of billings on
                  uncompleted contracts  $ 4,761,238  $ 3,306,673  $ 1,454,565
                                         ===========  ===========  ===========


               The backlog of unshipped  contracts being accounted for under the
               percentage of completion  method of accounting was  approximately
               $4.7 million at January 30, 1999.

                                       -6-
<PAGE>
NOTE 5         INVENTORY

               Inventory is stated at the lower of cost (first-in, first-out) or
               market.

               Inventories  and their effect on cost of sales are  determined by
               physical count for annual reporting purposes and are estimated by
               management for interim reporting purposes.

               Inventory consists of the following:     January 30,   August 1, 
                                                           1999         1998    
                                                       -----------  ----------- 

               Finished goods                          $ 5,589,834  $ 4,848,572
               Work-in-process                          15,956,247   11,333,936
               
               Raw material and purchased parts         12,112,629   13,012,754
                                                       -----------  -----------
               Total                                   $33,658,710  $29,195,262
                                                       ===========  ===========


NOTE 6         FIXED ASSETS

               Fixed assets consist of the following:

                                                       January 30,   August 1, 
                                                           1999         1998    
                                                       -----------  ----------- 

               Land                                    $   694,046  $   694,046
               Building                                  2,146,025    2,146,025
               Machinery and equipment                  12,724,509   11,370,262
               Furniture and fixtures                    1,541,532    1,484,310
               Leasehold improvements                    1,628,043    1,613,883
               EDP equipment                             1,968,413    1,891,272
               Transportation equipment                     30,103       30,103
                                                       -----------  -----------
                                                        20,732,671   19,229,901

               Less accumulated depreciation
                  and amortization                       7,334,117    6,490,392
                                                       -----------  -----------

               Net fixed assets                        $13,398,554  $12,739,509
                                                       ===========  ===========


NOTE 7         NET INCOME PER COMMON SHARE AND COMMON SHARE EQUIVALENTS

               During  the year  ended  August  1,  1998,  the  Company  adopted
               Statement  of  Financial  Accounting  Standard  "SFAS"  No.  128,
               "Earnings  Per Share." This  statement is effective for financial
               statements  issued for periods  ending  after  December 15, 1997.
               Basic and diluted  earnings per share have been  restated for all
               prior periods to reflect the adoption of SFAS No. 128.


NOTE 8         ACQUISITION

               In December 1998, the Company acquired certain selected assets of
               Acoma  Medical  Imaging  Inc. for  approximately  $1.4 million in
               cash,  including expenses,  payable over a three year period. The
               acquired assets consisted of inventory and technology.


NOTE 9         EFFECT OF NEW ACCOUNTING PRONOUNCEMENTS

               Reporting  Comprehensive  Income.  In June  1997,  the  Financial
               Accounting Standards Board "FASB" issued SFAS No. 130, "Reporting
               Comprehensive  Income."  This  statement is  effective  for years
               beginning  after December 15, 1997.  Management has evaluated the
               effect of this  statement  on its  financial  reporting  from the
               adoption  of  this  statement  and  has  found  that  no  further
               disclosures are needed.

               Disclosures   About   Segments  of  an  Enterprise   and  Related
               Information.  In  June  1997,  the  FASB  issued  SFAS  No.  131,
               "Disclosures   About   Segments  of  an  Enterprise  and  Related
               Information."  SFAS No. 131 requires the  reporting of profit and
               loss, specific revenue and expense items and assets for


                                       -7-

<PAGE>



               reportable segments. It also requires the reconciliation of total
               segment  revenues,  total segment profit and loss,  total segment
               assets  and  other  amounts   disclosed  for  segments,   to  the
               corresponding   amounts   in  the   general   purpose   financial
               statements.   This   statement  is  effective  for  fiscal  years
               beginning  after  December  15,  1997.  The  Company  has not yet
               determined  what  additional   disclosures  may  be  required  in
               connection with adopting SFAS No. 131.

               Disclosures about Pensions and Other Postretirement  Benefits. In
               February  1998,   the  FASB  issued  SFAS  No.  132,   "Employers
               Disclosures  about Pensions and Other  Postretirement  Benefits."
               This statement revises employers'  disclosures about pensions and
               other  postretirement  benefit  plans.  It does  not  change  the
               measurement  or  recognition  of those  plans.  SFAS  No.  132 is
               effective  for fiscal years  beginning  after  December 15, 1997.
               Management  does not  anticipate  that this statement will have a
               significant  effect  on  the  Company's   consolidated  financial
               statements.

               Disclosures about Derivative  Instruments and Hedging Activities.
               In June 1998,  the FASB  issued  SFAS No.  133,  "Accounting  for
               Derivative  Instruments  and  Hedging  Activities."  SFAS No. 133
               establishes  accounting  and reporting  standards for  derivative
               instruments and hedging activities. SFAS No. 133 is effective for
               all quarters of all fiscal  years  beginning  after  December 15,
               1999.  Management  does not  anticipate  that this statement will
               have  any  effect  on  the   Company's   consolidated   financial
               statements.



                                       -8-

<PAGE>



Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
         AND RESULTS OF OPERATIONS

This  Management  Discussion and Analysis of Financial  Condition and Results of
Operations contains forward looking statements.  Such statements involve various
risks that may cause actual results to differ  materially.  These risks include,
but are not  limited to, the  ability of the  Company to grow  internally  or by
acquisition  and  to  integrate  acquired   businesses,   changing  industry  or
competitive   conditions,   and  other  risks   referred  to  in  the  Company's
registration  statements  and periodic  reports  filed with the  Securities  and
Exchange Commission.

OVERVIEW

                 The  Company's  net sales  have  increased  as a result of both
internal growth and acquisitions. The Company has completed five acquisitions in
the past five years:  Dynarad (a designer and  manufacturer  of medical  imaging
systems and critical  electronic  subsystems) in fiscal 1993; Bertan (a designer
and  manufacturer  of precision high voltage power supplies and  instrumentation
for  medical  and  industrial   applications)  in  fiscal  1994;  Gendex-Del  (a
manufacturer of medical  imaging  systems) in fiscal 1996,  X-Ray  Technologies,
Inc.  (a  manufacturer  of medical  imaging  systems)  in fiscal  1998 and Acoma
Medical Imaging Inc. (a manufacturer of medical imaging systems) in fiscal 1999.
The  Company's  net sales have  increased  from  approximately  $24.3 million in
fiscal 1994 to approximately  $62.3 million in fiscal 1998, a compounded  annual
growth rate of 26.5%.

                 During the past five years the Company has grown internally and
through  acquisitions into a company whose  predominant  business is serving the
medical imaging and diagnostic markets.  The Company's net sales attributable to
medical imaging products have increased from approximately $9.4 million or 38.7%
of total net sales in fiscal 1994 to approximately $35.6 million or 65% of total
net sales and  approximately  $43.9  million or 71% of total net sales in fiscal
years 1997 and 1998, respectively.

                 Management  believes that recent cost containment trends in the
healthcare  industry have created  opportunities for its cost-effective  medical
imaging systems and subsystems in domestic and  international  markets.  Some of
these trends are increased demand for lower cost medical equipment,  outsourcing
of systems and critical  electronic  subsystems  by leading  original  equipment
manufacturers  ("OEMs"),  increased demand for certain diagnostic procedures and
lower cost medical services in the global marketplace.

RESULTS OF OPERATIONS

                 Net sales for the three  months  ended  January  30,  1999 were
approximately  $15.9 million as compared to approximately  $14.4 million for the
three months ended January 31, 1998, an increase of 10.5%. Net sales for the six
months ended  January 30, 1999 were  approximately  $30.7 million as compared to
approximately  $27.9  million  for the six months  ended  January 31,  1998,  an
increase of 10.2%.  These  increases  were due to internal  growth from existing
operations.

                 Cost of sales, as a percentage of net sales,  for the three and
six months ended January 30, 1999 were 58.5% compared to 59.0% and 59.7% for the
prior  corresponding  periods.  This  improvement in margins is due to operating
efficiencies and a change in product mix in the period.

                 Research  and  development  expenses  were  approximately  $1.5
million for the three month periods ended January 30, 1999 and January 31, 1998.
Research and development  expenses  increased to approximately  $3.0 million for
the six months ended  January 30, 1999 from  approximately  $2.7 million for the
six months  ended  January  31,  1998,  an increase of 9.4%.  The  increase  was
primarily  due to new product  development.  The Company  continues to invest in
research and development in order to introduce new state-of-the-art products for
its medical and industrial markets.

                 Selling, general and administrative expenses were approximately
$2.7  million,  or 17.3% of net sales,  for the three months  ended  January 30,
1999, as compared to approximately $2.5 million,  or 17.2% of net sales, for the
same  period  in the  prior  year,  a  decrease  of .1%.  Selling,  general  and
administrative  expenses were approximately $5.4 million, or 17.5% of net sales,
for the six months  ended  January 30, 1999 as  compared to  approximately  $4.9
million, or 17.5% of net sales, for the same period in the prior year.

                 Net interest  expense was  approximately  $16,000 for the three
months ended  January 30, 1999 as compared to interest  income of  approximately
$44,000 for the corresponding period in the prior year. Net interest expense was
approximately  $23,000 for the six months ended January 30, 1999, as compared to
net interest income


                                       -9-

<PAGE>



of  approximately  $99,000  for the  corresponding  period  in the  prior  year.
Interest  expense  resulted  because the  increase in long-term  debt  increased
interest  expense  in  excess  of  interest  income  for the three and six month
periods ended January 30, 1999.

                 Income tax expense was 31% of pre-tax  income for the three and
six months  ended  January 30,  1999 and 32% for the three and six months  ended
January 31, 1998.  The decrease from  statutory  rates is primarily due to sales
being made  through  the  Company's  Foreign  Sales  Corporation,  research  and
development and other tax credits.

                 Net income  increased  to  approximately  $1.6  million for the
three months ended January 30, 1999, an increase of  approximately  17.8%,  from
approximately $1.4 million for the prior  corresponding  period.  Basic earnings
per share for the three  months  ended  January 30, 1999  increased to $.21 from
$.18 for the three months ended January 31, 1998, an increase of 16.7%.  Diluted
earnings per share rose to $.20 from $.17 for the three months ended January 30,
1999 and January 31,  1998,  respectively,  an increase of 17.6%.  The  weighted
average number of common shares  outstanding at January 30, 1999 were 7,648,308,
as compared to  7,472,140 at January 31, 1998.  The weighted  average  number of
common  shares and common  share  equivalents  at January 30, 1999  increased to
8,205,600  from  8,172,285  at  January  31,  1998.  Net  income   increased  to
approximately  $3.0  million  for the six months  ended  January  30,  1999,  an
increase of approximately  15.8%, from  approximately $2.7 million for the prior
corresponding  period. Basic earnings per share for the six months ended January
30, 1999  increased to $.40 from $.35 for the six months ended January 31, 1998,
an increase of 14.3%.  Diluted earnings per share rose to $.37 from $.32 for the
six months  ended  January  30,  1999 and January  31,  1998,  respectively,  an
increase of 15.6%. The weighted  average number of common shares  outstanding at
January 30, 1999 were  7,648,361  as compared to  7,455,775 at January 31, 1998.
The weighted  average  number of common shares and common share  equivalents  at
January 30, 1999  increased to 8,174,078 from 8,172,142 at January 31, 1998. The
increase  in net income for the three and six month  periods  ended  January 30,
1999 was due to internal growth and improved gross margins.

                 The  backlog  of  unshipped  orders  at  January  30,  1999 was
approximately $41.6 million.


LIQUIDITY AND CAPITAL RESOURCES

                 The Company has funded its operations and acquisitions  through
a combination of cash flow from  operations,  bank borrowing and the issuance of
the Company's common stock.

                 Working  Capital.  At January 30, 1999 and August 1, 1998,  the
Company's  working  capital was  approximately  $44.5 million and $41.7 million,
respectively.  At such dates the Company  had  approximately  $900,000  and $3.4
million, respectively, in cash and cash equivalents.

                 Trade  receivables at January 30, 1999 increased  approximately
$1.0 million as compared to August 1, 1998,  primarily  due to  increased  sales
levels.

                 Cost  and   estimated   earnings   in  excess  of  billings  on
uncompleted  contracts  increased to  approximately  $4.8 million at January 30,
1999 from  approximately  $3.3 million at August 1, 1998 due to additional  work
performed  during  the  period on long term  contracts  accounted  for under the
percentage of completion method of accounting.

                 Inventory  at January 30,  1999  increased  approximately  $4.5
million,  as compared to August 1, 1998,  primarily  because of higher levels of
sales of medical  systems and  subsystems  and the  acquisition of Acoma Medical
Imaging Inc. inventory during the period.

                 Prepaid  expenses and other current  assets at January 30, 1999
increased  approximately  $825,000,  as  compared  to  August  1,  1998,  due to
increases  in prepaid  trade  show  expenses  and  prepaid  expenses  related to
increased acquisition activity.

                 Trade accounts payable increased  approximately $1.3 million at
January 30, 1999 from August 1, 1998 primarily because of higher levels of sales
of medical systems and subsystems.

                 Credit Facility and Borrowing. At January 30, 1999, the Company
had a $14.0 million revolving credit line and a $10.0 million acquisition credit
line. The available portion of the revolving credit line was approximately $13.5
million,  after  deducting  borrowings  of $300,000 and  outstanding  letters of
credit of approximately $208,000. $9.5 million was available under the Company's
acquisition credit line.



                                      -10-

<PAGE>
                 Capital  Expenditures.  The  Company  continues  to  invest  in
capital  equipment,  principally for its manufacturing  operations,  in order to
improve its  manufacturing  efficiency  and  capacity.  The Company has expended
approximately  $1.5 million for capital equipment for the six month period ended
January 30, 1999.

                 The Company anticipates that cash generated from operations and
amounts  available  under its bank  lending  facilities  will be  sufficient  to
satisfy its current operating cash needs.

                 Shareholders'   Equity.   Shareholders'   equity  increased  to
approximately $62.3 million at January 30, 1999 from approximately $59.5 million
at August 1, 1998,  primarily  due to the results of  operations.  Additionally,
during the period 108,436 stock options and 15,000 warrants were exercised, with
proceeds of $328,500  and 97,141  shares of common stock were  repurchased  at a
cost of $692,474.

                 Year 2000. The Company has initiated a company-wide program and
developed a formal plan to identify, evaluate and implement changes to products,
computer systems,  applications and  infrastructure  necessary to achieve a year
2000 date  conversion  with no effect on  customers  or  disruption  to business
operations.  These actions are necessary to ensure that all systems and business
applications will recognize and process the year 2000 and beyond.

                 The Company uses purchased  software  programs for a variety of
functions,  including drafting and design,  general accounting and manufacturing
applications.  Currently,  all of the Company's products and software for design
and drafting applications are fully compliant. The Company's systems for general
accounting and manufacturing have been evaluated and steps to achieve compliance
are being  implemented  and are expected to be fully compliant by July 31, 1999,
although  there can be no  assurance  that it will.  At this time,  the  Company
believes  that it does not have any internal  mission  critical year 2000 issues
that it cannot remedy.

                 As  part  of  the  year  2000  readiness  process,  significant
customers,  service  providers,  vendors and  suppliers  who are  believed to be
critical to business  operations  after January 1, 2000 have been identified and
steps  are  underway  in an  attempt  to  reasonably  ascertain  their  stage of
readiness.   The  Company  is   surveying   them   primarily   through   written
correspondence.  With respect to mission  critical  third  parties,  the Company
intends to create  contingency  plans to  mitigate  its  exposure  to such third
parties  that are not year 2000  compliant.  In the event any  mission  critical
third  parties do not  achieve  full  compliance,  the  Company  believes it has
sufficient  alternative  resources  upon which to rely.  Despite  its efforts to
ascertain the readiness of its customers,  suppliers and service providers,  the
Company  cannot be certain as to the actual year 2000  readiness  of these third
parties or the impact  their  non-compliance  may have on the  Company's  future
financial position, the results of its operations or its cash flows.

                 With respect to the Company's  internal  year 2000  compliance,
the Company  expects to incur  internal  staff costs,  as well as consulting and
other  expenses  and  believes  that the total costs to be incurred for all year
2000  compliance  related  projects  will  not  have a  material  effect  on the
Company's  future  financial  position,  results of its  operations  or its cash
flows.

                 The Company  expects to achieve full  compliance  no later than
September 30, 1999.

EFFECTS OF NEW ACCOUNTING PRONOUNCEMENTS

                 Reporting  Comprehensive  Income. In June 1997, the FASB issued
SFAS No. 130, "Reporting  Comprehensive Income." This statement is effective for
years beginning after December 15, 1997.  Management has evaluated the effect of
this  statement on its financial  reporting  from the adoption of this statement
and has found that no further disclosures are needed.

                 Disclosures   About  Segments  of  an  Enterprise  and  Related
Information.  In June 1997,  the FASB issued SFAS No.  131,  "Disclosures  About
Segments of an Enterprise  and Related  Information."  SFAS No. 131 requires the
reporting of profit and loss,  specific revenue and expense items and assets for
reportable  segments.  It also  requires  the  reconciliation  of total  segment
revenues,  total segment profit and loss, total segment assets and other amounts
disclosed  for segments,  to the  corresponding  amounts in the general  purpose
financial  statements.  This  statement is effective for fiscal years  beginning
after  December 15, 1997.  The Company has not yet  determined  what  additional
disclosures may be required in connection with adopting SFAS No. 131.

                 Disclosures about Pensions and Other  Postretirement  Benefits.
In February 1998,  the FASB issued SFAS No. 132,  "Employers  Disclosures  about
Pensions and Other  Postretirement  Benefits." This statement revises employers'
disclosures about pensions and other  postretirement  benefit plans. It does not
change the

                                      -11-
<PAGE>
measurement or recognition of those plans.  SFAS No. 132 is effective for fiscal
years  beginning  after December 15, 1997.  Management  does not anticipate that
this  statement  will have a significant  effect on the  Company's  consolidated
financial statements.

                 Disclosures   about   Derivative    Instruments   and   Hedging
Activities.  In June  1998,  the FASB  issued  SFAS  No.  133,  "Accounting  for
Derivative  Instruments  and  Hedging  Activities."  SFAS  No.  133  establishes
accounting  and  reporting  standards  for  derivative  instruments  and hedging
activities.  SFAS No. 133 is  effective  for all  quarters  of all fiscal  years
beginning  after December 15, 1999.  Management  does not  anticipate  that this
statement  will  have  any  effect  on  the  Company's   consolidated  financial
statements.


Item 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

                 Not applicable.


                                      -12-

<PAGE>



                                     PART II

Item 1.        Legal Proceedings

                        None

Item 2.        Changes in Securities

                        None

Item 3.        Defaults on Senior Securities

                        None

Item 4.        Submission to a Vote of Security Holders

                        At the annual  meeting of  stockholders  of the  Company
                        held on February 11, 1999, the stockholders  elected the
                        following  directors:  Natan V. Bertman,  David Michael,
                        Seymour  Rubin,  James  Tiernan,  Leonard A. Trugman and
                        Roger J. Winston.

                        Election of Directors          For           Withheld   
                        ---------------------       ---------        --------   

                        Leonard A. Trugman          6,953,087          92,441
                        Natan V. Bertman            6,953,152          92,376
                        David Michael               6,954,106          91,422
                        Seymour Rubin               6,952,527          92,601
                        James Tiernan               6,952,801          92,727
                        Roger J. Winston            6,948,791          96,737


Item 5.        Other Information

                        None


Item 6.        Exhibits and Reports on Form 8-K

               (a)      Exhibits:   Exhibit 11 - Computation  of  Earnings   per
                                                 Common Share
                                    Exhibit 27 - Financial Data Schedule


               (b)      Report on Form 8-K:   None



                                      -13-

<PAGE>



                                   SIGNATURES


        Pursuant to the requirements of the Securities and Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned, thereunto duly authorized.










                                               DEL GLOBAL TECHNOLOGIES CORP.




                                              /S/LEONARD A. TRUGMAN
                                              ---------------------
                                              Leonard A. Trugman
                                              Chairman of the Board,
                                              Chief Executive Officer
                                              and President




                                              /S/MICHAEL H. TABER
                                              -------------------
                                              Michael H. Taber
                                              Chief Financial Officer,
                                              Vice President of Finance
                                              and Secretary



Dated: March 11, 1999







                                      -14-